🇺🇸 FDA
Patent

US 10745680

Factor IX fusion proteins and methods of making and using same

granted A61KA61K38/00A61K9/0019

Quick answer

US patent 10745680 (Factor IX fusion proteins and methods of making and using same) held by BIOVERATIV THERAPEUTICS INC. expires Mon Aug 13 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
BIOVERATIV THERAPEUTICS INC.
Grant date
Tue Aug 18 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 13 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
27
CPC classes
A61K, A61K38/00, A61K9/0019, A61P, A61P7/04